These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 31640764)

  • 1. Myeloid-derived suppressor cells in hematological malignancies: friends or foes.
    Lv M; Wang K; Huang XJ
    J Hematol Oncol; 2019 Oct; 12(1):105. PubMed ID: 31640764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocytic Myeloid Derived Suppressor Cells in Hematological Malignancies.
    Palumbo GA; Parrinello NL; Giallongo C; D'Amico E; Zanghì A; Puglisi F; Conticello C; Chiarenza A; Tibullo D; Raimondo FD; Romano A
    Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31683978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid-derived suppressor cells in B cell malignancies.
    Yazdani Y; Mohammadnia-Afrouzi M; Yousefi M; Anvari E; Ghalamfarsa G; Hasannia H; Sadreddini S; Jadidi-Niaragh F
    Tumour Biol; 2015 Sep; 36(10):7339-53. PubMed ID: 26330296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid-derived suppressor cells: The green light for myeloma immune escape.
    Malek E; de Lima M; Letterio JJ; Kim BG; Finke JH; Driscoll JJ; Giralt SA
    Blood Rev; 2016 Sep; 30(5):341-8. PubMed ID: 27132116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutualistic Effects of the Myeloid-Derived Suppressor Cells and Cancer Stem Cells in the Tumor Microenvironment.
    Tanriover G; Aytac G
    Crit Rev Oncog; 2019; 24(1):61-67. PubMed ID: 31679221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid-derived suppressor cells endow stem-like qualities to multiple myeloma cells by inducing piRNA-823 expression and DNMT3B activation.
    Ai L; Mu S; Sun C; Fan F; Yan H; Qin Y; Cui G; Wang Y; Guo T; Mei H; Wang H; Hu Y
    Mol Cancer; 2019 Apr; 18(1):88. PubMed ID: 30979371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of myeloid-derived suppressor cells in hematologic malignancies.
    Gunes EG; Rosen ST; Querfeld C
    Curr Opin Oncol; 2020 Sep; 32(5):518-526. PubMed ID: 32675593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond bystanders: Myeloid cells in chronic lymphocytic leukemia.
    Hanna BS; Öztürk S; Seiffert M
    Mol Immunol; 2019 Jun; 110():77-87. PubMed ID: 29173971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recruited monocytic myeloid-derived suppressor cells promote the arrest of tumor cells in the premetastatic niche through an IL-1β-mediated increase in E-selectin expression.
    Shi H; Zhang J; Han X; Li H; Xie M; Sun Y; Liu W; Ba X; Zeng X
    Int J Cancer; 2017 Mar; 140(6):1370-1383. PubMed ID: 27885671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phytochemicals inhibit the immunosuppressive functions of myeloid-derived suppressor cells (MDSC): Impact on cancer and age-related chronic inflammatory disorders.
    Salminen A; Kaarniranta K; Kauppinen A
    Int Immunopharmacol; 2018 Aug; 61():231-240. PubMed ID: 29894862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloid-derived suppressor cells as therapeutic target in hematological malignancies.
    De Veirman K; Van Valckenborgh E; Lahmar Q; Geeraerts X; De Bruyne E; Menu E; Van Riet I; Vanderkerken K; Van Ginderachter JA
    Front Oncol; 2014; 4():349. PubMed ID: 25538893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid-derived suppressor cells: their role in the pathophysiology of hematologic malignancies and potential as therapeutic targets.
    Younos IH; Abe F; Talmadge JE
    Leuk Lymphoma; 2015; 56(8):2251-63. PubMed ID: 25407654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function.
    Nam S; Kang K; Cha JS; Kim JW; Lee HG; Kim Y; Yang Y; Lee MS; Lim JS
    J Leukoc Biol; 2016 Dec; 100(6):1273-1284. PubMed ID: 27601624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid-derived suppressor cells in hematologic malignancies: two sides of the same coin.
    Yu S; Ren X; Li L
    Exp Hematol Oncol; 2022 Jul; 11(1):43. PubMed ID: 35854339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Circulating Myeloid Suppressor Cells and Their Role in Tumour Immunology].
    Pilatova K; Budinská E; Bensciková B; Nenutil R; Šefr R; Fedorová L; Hanáková B; Brychtová V; Zdražilová Dubská L
    Klin Onkol; 2017; 30(Supplementum1):166-169. PubMed ID: 28471197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloid-derived suppressor cells accumulate among myeloid cells contributing to tumor growth in matrix metalloproteinase 12 knockout mice.
    Li J; Zhang X; Liu Q; Yang M; Zhou Z; Ye Y; Zhou Z; He X; Wang L
    Cell Immunol; 2018 May; 327():1-12. PubMed ID: 29555056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction Between MDSC and NK Cells in Solid and Hematological Malignancies: Impact on HSCT.
    Tumino N; Di Pace AL; Besi F; Quatrini L; Vacca P; Moretta L
    Front Immunol; 2021; 12():638841. PubMed ID: 33679798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long Non-Coding RNA HOXA Transcript Antisense RNA Myeloid-Specific 1-HOXA1 Axis Downregulates the Immunosuppressive Activity of Myeloid-Derived Suppressor Cells in Lung Cancer.
    Tian X; Ma J; Wang T; Tian J; Zhang Y; Mao L; Xu H; Wang S
    Front Immunol; 2018; 9():473. PubMed ID: 29662483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematological Malignancy-Derived Small Extracellular Vesicles and Tumor Microenvironment: The Art of Turning Foes into Friends.
    Gargiulo E; Paggetti J; Moussay E
    Cells; 2019 May; 8(5):. PubMed ID: 31137912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematological malignancies: disease pathophysiology of leukemic stem cells.
    Ramdass B; Chowdhary A; Koka PS
    J Stem Cells; 2013; 8(3-4):151-87. PubMed ID: 24699024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.